About the event
3DMedLIVE 2020: 3D printing in surgery
Convening a community of innovation and best practice to advance surgical applications of 3D printing.
Following overwhelmingly positive feedback from the inaugural 3DMedLIVE in 2019, we are back for the 2nd annual 3DMedLIVE in October 2020.
3DMedLIVE originated in response to calls to bring together surgeons, radiologists, biomedical engineers, 3D printing technicians, medical modellers and healthcare professionals, with regulators, engineers, start-ups and suppliers.
Co-hosted by 3DMedNet and the Journal of 3D Printing in Medicine, 3DMedLIVE is a two-day conference which aims to bring the 3D printing in surgery community to life, encouraging collaboration, conversation and the sharing of knowledge, essential to the progression of the field.
As the future of surgery steers towards a demand for personalised approaches to care and customised solutions, 3DMedLIVE keeps the patient at the heart, encouraging dynamic, conversation-led and solution-focused sessions, including case study presentations from the operating surgeons themselves.
Attendees can expect the same, high calibre agenda with high impact discussion from 3DMedLIVE 2019 at 3DMedLIVE 2020, as we continue the conversation to advance the field, together.
As well as providing a platform for the presentation and discussion of scientific ideas, offering the opportunity to connect with other innovators is core to the mission of 3DMedLIVE. In line with the ethos of 3DMedNet, communication is key to progressing this field, so over the two days there will be plenty of opportunities to network, meet new contacts and collaborate on ideas.
As final details are yet to be announced, watch this space for more information about what to expect from 3DMedLIVE 2020.
What will be covered?
- The future of innovation in surgery
- 3D-printed solutions for complex surgical challenges
- Delivering medical devices into uncertain regulatory environments
- Funding innovation and the adoption of novel technologies
- Case study presentations and discussions from surgeons and clinicians
Who will be there?
Over two days, we’ll hear case studies directly from pioneering surgeons and researchers who are already utilising 3D printing technologies in their practice, plus panel discussions and roundtables with regulators, manufacturers and funders.
- Surgeons, radiologists and a range of healthcare practitioners from multi-disciplinary teams in the NHS and private hospitals
- Biomedical engineers
- Information governance and finance specialists from NHS and private hospitals
- Researchers and decision makers in engineering, medical physics and innovation
- Medtech start-ups
- Legal and policy advisors
- Venture capitalists
- Central government
- 3D printing hardware, software and consumable suppliers from across the UK and Europe
What will the event look like?
Leave the PowerPoint at home: 3DMedLIVE is dynamic, conversation-led and solution-focused, with the patient at the heart.
- Solution-focussed sessions, led by key opinion leaders and industry experts
- Panel discussions and roundtables
- Case studies, proving the concept and benchmarking your experience
- Mix directly with experts in surgical practice, regulation and bringing 3D printing technology into clinical practice
Book your tickets now to secure your place or join 3DMedNet for exclusive content from 3DMedLIVE 2019.
Reflecting on 3DMedLIVE 2019: 3D printing in surgery
In 2019, internationally renowned experts shared their experiences and insights in working with 3D printing technologies among other innovations in the surgical space, as two separate streams chaired by Dietmar Hutmacher (Queensland University of Technology, Australia) and Freya Leask (Future Science Group) addressed key clinical, business-case, regulatory and funding-based questions.
Keynote topics included The Future of Surgery and the NHS Long Term Plan with Richard Kerr (RCS Commission on the Future of Surgery, UK), Lorna Marson (University of Edinburgh, UK) and Adrian Sugar (Centre for Applied Reconstructive Technologies in Surgery, UK), as well as an international perspective on today’s patient care dynamic from Amy Alexander (Mayo Clinic; MN, USA). Discussions steered towards the future use of innovative technologies in surgical training and practice set the scene, as subsequent sessions highlighted key milestones in patient and innovator journeys.
“It was fascinating to hear about the RCS Commission on the Future of Surgery and how the uptake of exciting key technologies such as 3D printing, artificial intelligence and virtual reality could impact how the NHS delivers healthcare going forward. These remarkable advancements are pushing the boundaries of what is possible in surgery, making it a truly exciting time for the healthcare profession and a promising time for the patient.” – Adam Price-Evans, Managing Commissioning Editor, Future Science Group
Attendees participating in the clinical stream benefited from presentations led by some of the UK and Europe’s top surgeons. David Dunaway (Great Ormond Street Hospital, UK), Pankaj Chandak (Guy’s and St Thomas’ Hospitals, UK) and Tim Brown (Belfast City Hospital, UK) presented complex surgical challenges, discussing the applications of different 3D-printed solutions. From craniopagus twin separation to paediatric transplant procedures, the clinical stream demonstrated the versatility of surgical applications of 3D printing and the real-world benefits of surgeons’ innovative approaches to surgical challenges.
“David Dunaway spoke about separating craniopagus conjoined twins (joined at the head), which was pretty amazing. We were shown various 3D images and models, including bone and vascular components, used to plan the surgery. David mentioned that one of the problems with this type of complex surgery is an overload of information, but 3D modeling helps to manage this.” – Laura Dormer, Editorial Director, Future Science Group
The business-case stream addressed strategic questions and challenges related to the regulation of devices, opportunities for funding and the process of adoption of innovative technologies into the NHS. Representatives from industry described different models of working – from embedded hubs to outsourced services – and entrepreneurs described their experience in the development of novel, 3D-printed concepts within the medical space.
With a short focus on bioprinting, biofabrication and the translation of futuristic cell-based 3D printing therapy opportunities into clinical practice, 3DMedLIVE 2019 was drawn to a close with a focus on what may be possible as research advances. Tim Gunn (Proximie, UK) delivered a final session which explored the application of augmented reality and how 3D technologies in general could develop and advance surgery around the world.
“It was exciting to hear about the promise bioprinting has in the field; I look forward to being able to share real clinical case studies in the years to come, building on the great research which was presented this year.” – Freya Leask, Publisher, Future Science Group
3DMedLIVE 2019: 3D printing in surgery has been regarded as a tremendous success throughout the field of medical 3D printing and we are looking forward to continuing this enthusiasm into hosting 3DMedLIVE 2020.